CPM
CLBT icon

Crescent Park Management’s Cellebrite CLBT Stock Holding History

Crescent Park Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23,449
Closed -$423K – 15
2025
Q4 		$423K Sell
23,449
-292,961
-93% -$5.26M 0.26% 25
2025
Q3 		$5.86M Sell
316,410
-253,822
-45% -$3.99M 2.35% 16
2025
Q2 		$9.12M Sell
570,232
-113,179
-17% -$2.02M 3.51% 12
2025
Q1 		$13.3M Sell
683,411
-1,179,071
-63% -$24.8M 6.19% 5
2024
Q4 		$41M Buy
1,862,482
+142,534
+8% +$2.74M 15.71% 2
2024
Q3 		$29M Buy
1,719,948
+1,667,994
+3,211% +$24.8M 11.53% 2
2024
Q2 		$621K Hold
51,954
– – 0.29% 23
2024
Q1 		$576K Sell
51,954
-274,624
-84% -$2.8M 0.22% 23
2023
Q4 		$2.83M Buy
326,578
+27,329
+9% +$212K 0.61% 22
2023
Q3 		$2.29M Buy
299,249
+18,685
+7% +$140K 0.54% 24
2023
Q2 		$2.02M Buy
280,564
+25,451
+10% +$148K 0.59% 21
2023
Q1 		$1.55M Sell
255,113
-113,695
-31% -$616K 0.51% 21
2022
Q4 		$1.61M Sell
368,808
-260,921
-41% -$1.17M 0.51% 20
2022
Q3 		$2.47M Buy
629,729
+28,192
+5% +$141K 0.59% 24
2022
Q2 		$3.07M Buy
601,537
+14,633
+2% +$76.1K 0.66% 25
2022
Q1 		$3.76M Sell
586,904
-403,266
-41% -$2.67M 0.61% 27
2021
Q4 		$7.94M Sell
990,170
-112,307
-10% -$1.06M 1.29% 24
2021
Q3 		$10.2M Buy
+1,102,477
New +$11.5M 1.5% 25

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Crescent Park Management's CLBT Position: Q1 2026 in Review

Crescent Park Management sold out of Cellebrite (CLBT) in Q1 2026, closing a stake of 23,449 shares — an estimated $423K sold.

Crescent Park Management first reported a position in CLBT in Q3 2021 and held it in 18 quarters. The position peaked at $41M in Q4 2024. 221 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Crescent Park Management reported no remaining Cellebrite position as of Q1 2026 after selling out during the quarter.
  • Crescent Park Management sold 23,449 Cellebrite shares in Q1 2026, an estimated $423K.
  • Crescent Park Management first reported a position in Cellebrite in Q3 2021 and held it in 18 quarters.
  • Crescent Park Management's Cellebrite position peaked at $41M in Q4 2024.
  • 221 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Crescent Park Management's 13F filing for Q1 2026, filed 13 May 2026.